Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Gynecol Oncol. 2015 Apr 16;138(1):24–29. doi: 10.1016/j.ygyno.2015.04.006

Table 1.

Patient characteristics

Characteristic Category Dalantercept
n %
Age Group 40–49 1 3.6
50–59 9 32.1
60–69 13 46.4
70–79 5 17.9
Ethnicity Hispanic or Latino 2 7.1
Non-Hispanic 23 82.1
Unknown/Not specified 3 10.7
Race White 24 85.7
Black/African American 3 10.7
Unspecified 1 3.6
Performance Status 0 20 71.4
1 8 28.6
Cell Type/Grade Endometrioid, grade 1 4 14.3
Endometrioid, grade 2 6 21.4
Serous 15 53.6
Clear Cell 2 7.1
Mixed Epithelial 1 3.6
Prior Chemotherapy 1 Prior Regimen 23 82.1
2 Prior Regimens 5 17.9
Prior Radiation No 10 35.7
Yes 18 64.3
Prior Hormonal No 25 89.3
Therapy Yes 3 10.7
Prior Surgery Yes 28 100.0